RBC Capital analyst Sean Dodge lowered the firm’s price target on Teladoc to $18 from $25 but keeps an Outperform rating on the shares. The company’s Integrated Care segment upside helped offset weakness in BetterHelp, where revenue missed the firm’s forecast and EBITDA margin came in near the low-end of guidance, the analyst tells investors in a research note. The number of paying BetterHelp users has also declined for a third consecutive quarter, but the management laid out plans to re-accelerate growth via innovating around all aspects of user acquisition, monetization, and retention, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Options Volatility and Implied Earnings Moves Today, April 25, 2024
- Optum virtual care exit ‘clear positive’ for Teladoc, says BofA
- UnitedHealth’s Optum closing virtual care business, Endpoints says
- Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
- Teladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25